RecallRadar

FDA Drug recall D-1422-2012

Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Divisi…

On 2012-07-25 the FDA classified a Class III recall of Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Divisi… by Pack Pharmaceuticals, citing labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1422-2012
ClassificationClass III
Statusterminated
Initiated2012-03-09
Published2012-07-25
Last updated2026-09-13 11:51 UTC
CompanyPack Pharmaceuticals
DistributionUS

Product

Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.

Reason

Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.

Identifiers

ndc16571-411-10
ndc16571-412-10
ndc16571-412-50
ndc16571-413-05
code_infoLot #: : PUB1040, Exp 08/2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1422-2012%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.